Andson Biotech
YC W22Atlanta, US · Founded 2021 · 4 employees · 1 known investors
Andson Biotech provides chemical analysis technology for pharmaceutical manufacturers to measure hard-to-detect compounds during the development and production of cell therapies and biologics, supporting both drug development workflows and quality assurance processes.
Founders & leadership· Y Combinator alumni (W22)
Mason ChilmonczykinFounder
Investors · 1
In the news
- Y Combinator-backed Andson Biotech in Atlanta raises $5 Millionhypepotamus.com · 2025
- Y Combinator-backed Andson Biotech in Atlanta raises $5 Million - Hypepotamushypepotamus.com · 2025
- Andson Biotech raises $4.7 million to scale flagship innovation and support expansion - Atlanta Business Chroniclebizjournals.com · 2025
- Andson Biotech Secures $5.0M in Funding to Accelerate Commercialization, Expand Product Portfolioandsonbiotech.com · 2025
- Andson Biotech Raises $3.6M in Seed Round Funding – Biolocitybiolocity.gatech.edu · 2024
- Andson Biotech - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2022